Introduction
Two alternative mechanisms have been suggested to explain the source of B-1 cells (1, 2) , a minority population of B cells marked by distinctive phenotype, physiology, anatomic distribution and antibody repertoire. One explanation, based on studies of B-1 cells arising spontaneously in mice that have not been intentionally immunized, suggests that all B-1 cells are the progeny of a distinct lineage of lymphopoietic cells, mostly active in early life, and that the other characteristics, including the antibody repertoire, are inherent in the lineage (3) (4) (5) . The other explanation, based on findings that spontaneously arising B-1 cells are the product of antigen driven selection and proliferation (6) and that the B-1 phenotype can be induced, on normal splenic B cells, by crosslinking of surface Ig in the absence of a cognate T helper cell interaction (7) , suggests that the B-1 phenotype is a marker for differentiated cells that have made a positive response to T-mdependent (Tl) antigen, that the phenotype is induced as a result of that response and, thus, that the B-1 cells that appear spontaneously do so in response to self antigens.
Under the lineage hypothesis, de novo development of B-1 cells in the mouse is not dependent on antigen encounter, but is an intrinsic property of developmentally committed precursors Generation of B-1 cells is confined to early life; in the adult they are maintained as a self-replenishing cell population. Once a mouse reaches adulthood, it is implied that the mature B-1 cell population expresses the full repertoire of antibody specificities available to B-1 cells. The induced differentiation hypothesis, on the other hand, predicts that it should be possible to generate B-1 cells in the adult by immunizing with a Tl foreign antigen that the animal has not previously encountered.
Our objective in this report is to distinguish between the two explanations by determining the origin and phenotype of B cells that respond to immunization with the non-self TI-2 antigen polyvinyl pyrrolidinone (PVP, also called polyvinyl pyrrolidone).
We find that in radiation chimeras constructed from allotypemarked adult bone marrow and peritoneal cell donors, all of the cells capable of responding to PVP develop from the bone marrow donors, the peritoneal B cells do not participate in this response. However, after immunization, the cells making anti-PVP IgM reside in the spleen and have the phenotypic characteristics of B-1 cells; they are B220 |OW , CDS 1 ™, lgM ht 9 h , IgD 1 ™, CD43 + and CD23".
Methods

Mice
(2 a 4 b ) mice were bred in our own mouse colony. 2 a 4 b -lgH a mice have been recently produced in our mouse colony by crossing 2 a 4 b mice to C57BL/6-lgH a (B6.C20) mice (produced by G. Bosma; our breeding stock was a generous gift of P. Cohen and B. Eisenberg, Division of Rheumatology, School of Medicine, UNC-CH), followed by backcrossing to 2 a 4 b . At each generation, lgH ab heterozygotes were selected for further backcrossing. After five backcross generations heterozygous male and female mice were intercrossed and the lgH aa homozygous mice were bred to produce the mice used in the experiments reported here. These mice are skin graft compatible with 2 a 4 b . Backcrossing of heterozygous animals has been continued and we are now at the 10th backcross generation.
Antigens and immunization
PVP, molecular weight 360 kDa (PVP-360) and molecular weight 10 kDa (PVP-10), were obtained from Sigma (St Louis, MO). The standard immunization involved injecting mice i.p. with 1 ng PVP-360 dissolved in PBS, without adjuvant.
Production and sequencing of PVP-reactive hybridomas
An adult 2 a 4 b mouse was immunized once with 1 ng PVP-360 and 4 days later the spleen cells from that mouse were fused with P3X-63-Ag8.653 myeloma cells PVP-specific hybridomas were selected by assaying supernatant by ELISA on PVP-10-coated plates and developing those plates with a mixture of alkaline phosphatase (AP)-conjugated goat antimouse K and X chains (to detect antibodies of any isotype). The heavy and light chains used by each hybridoma were determined by ELISA techniques described in the ELISA and ELISAspot techniques section. The heavy chains of these hybridomas were sequenced by isolating mRNA from cultured cells with the Micro Fast-Track kit by InVitroGen (San Diego, CA) These mRNAs were used with the 5' RACE System for the Rapid Amplification of cDNA Ends from BRL Life Technologies (Gaithersburg, MD). The nested primers that we used in the 5' RACE procedures were produced in the Lineberger Comprehensive Cancer Center Nucleic Acids Core Facility, University of North Carolina, and were designed as follows. The initial cDNAs were synthesized from mRNA using, for IgM, the gene-specific primer-1 (GSP1)5'-AGGGG-GCTCTCGCAGGAGACG-3' and for lgG3 the GSP1 5'-TGTG-TCACTGCAGCCAGGGACC-3'. After poly-C tailing, the cDNAs were amplified by PCR using the anchor primers supplied with the kit and internal or nested GSP2s. The IgM GSP2 is 5'-GGGAAGACATTTGGGAAGGACTGA-3' and the lgG3 GSP2 is 5'-AAGGGATAGACAGATGGGGCTGTT-3\ The DNA products of the 5' RACE procedure were cloned into the pGEM-T vector and transformed into the Escherichia coli strain JM109 from Promega (Madison, Wl). These clones were sequenced with the Sequenase Version 2.0 kit from US Biochemicals (Cleveland, OH).
Flow cytometry and cell sorting
Flow cytometry and cell sorting were performed using a Coulter EPICS 752 system. Cells were analyzed and sorted using a 76 (im quartz flow cell (Coulter Electronics, Hialeah, FL) or in some cases analyzed using a 250 (im quartz flow cell modified as described (8) . Light scatter measurements (forward angle and 90°) and excitation of fluorescein and phycoerythrin (PE) were done using 300 mW of the 488 nm line from an argon ion laser The laser beam was focused to 16x50 |iM using the confocal lens assembly. Data collection, analysis and sort control were done using the CICERO hardware and software (Cytomation, Fort Collins, CO). All fluorescence data were collected using three-decade log amplifiers. Red and green fluorescence signals were separated using a 550 nm long-pass dichroic filter. Emission from fluorescein was measured through a 525 ± 10 nm bandpass filter and that from PE was measured through a 575 ± 10 nm bandpass filter.
Antibodies for immunofluorescence
FITC-anti-IgM was purchased from FisherBiotech (Pittsburgh, PA). Biotinanti-Ly-1 (CD5, clone 53-7.3), FITC-anti-Ly-5 (B220) (CD45R, clone RA3-6B2), Biotin anti-lgD b (clone 217-170), FITC-anti-lgM b (clone AF6-78), FITC-conjugated rat antimouse IgM (clone R6-60.2) and R-PE-conjugated anti-CD43 (clone S7) were purchased from PharMmgen (San Diego, CA). R-PE-conjugated streptavidm was purchased from Jackson Immunoresearch (West Grove, PA). The anti-CD23 mAb B3B4 (9) was a gift of Dr T. Waldschmidt (University of Iowa) and was biotmylated in our laboratory.
Construction of radiation chimeras
Recipients were irradiated with 850 rad from a cesium source and reconstituted, between 2 and 5 h later, with bone marrow cells alone or bone marrow and peritoneal cells from strains of mice differing at Ig heavy chain allotype. On every day that irradiated mice were reconstituted, one control mouse was not reconstituted. These mice always died between 7 and 12 days after irradiation Peritoneal cells (PerC) were obtained by washing the peritoneal cavities of donor mice twice with 5 ml of Hanks balanced salt solution with 1 % heatinactivated FCS (HBSS-1% FCS). Bone marrow (BM) cells were obtained by flushing the femurs and tibias of donor mice with HBSS-1% FCS through a 25 gauge needle, gently aspirating the cells with a sterile Pasteur pipette and removing the clumps by filtering the cells through Nitex (Tetko, Elmira, NY) BM cells from one donor were used for four irradiated recipients and PerC from one donor were used for each 
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ELISA and ELISAspot techniques
PVP-specific antibodies in serum were quantified by diluting the serum in ELISA wash buffer [PBS, pH 7 4, with 0.1% Tween-20 (Sigma), EWB] and applying 100 \i\ aliquots to ELISA plates (Costar 3590) which had been coated with PVP-10 at 100 (ig/ml in alkaline carbonate buffer. For quantification of IgM and lgG3 PVP-specific antibodies, dilutions of a standard curve of Ig from hybridomas of those isotypes specific for PVP were included on the same plate. Because we do not have PVP-specific hybridomas of the IgGi, lgG2 or IgA isotypes, PVP-specific antibodies were quantitated by comparison with a standard curve of purified reference antibodies of those isotypes (ICN ImmunoBiochemicals, Lisle, IL) trapped on unlabeled goat anti-mouse IgG 1, lgG2b, lgG2a or IgA (FisherBiotech, Pittsburgh, PA). After at least 2 h incubation at 4°C, the plates were washed with EWB and 100 |il aliquots of AP-conjugated goat anti-mouse Ig (isotype specific) (FisherBiotech) at 0.2 ng/ml in EWB were incubated in each well for 2 h at room temperature. The wells were washed four times with EWB and 100 nl of 2.3 mM p-nitrophenyl phosphate (Sigma) in substrate buffer (1 M diethanolamine, 0.5 mM MgCI 2 , pH 9.8) was added to each well. After 1-2 h at 37°C the plates were read on an automatic plate reader (Biotek Instruments, Winooskie, VT).
The ELISAspot technique was performed precisely according to Sedgwick and Holt (10) . Single-cell suspensions were prepared from spleens and red blood cells removed by Trisammonium chloride lysis. The remaining nucleated cells were resuspended in B cell medium (RPMI 1640 with 10% FCS, containing 2 mM L-glutamine, 100 |iM non-essential amino acids, 1 mM sodium pyruvate and 5x10 5 M 2-mercaptoethanol; BCM), carefully counted and diluted in BCM by 3-fold increments over the range from 10 7 to 100 cells/ml. Aliquots of 100 |il of these diluted cells were added to wells of ELISA plates which had been coated with goat anti-mouse IgM or with PVP-10 as described previously. After at least 2 h incubation at 37°C, the plates were washed with EWB and 100 \i\ aliquots of AP-conjugated goat anti-mouse IgM (FisherBiotech) at 0.2 ng/ml in EWB were incubated in each well for 2 h at room temperature. The wells were washed four times with EWB and 100 nl of BCIP substrate in agarose was added to each well precisely as described by Sedgwick and Holt (10) . After overnight incubation at room temperature, spots were counted using a dissecting microscope with substage illumination. Results are expressed as the number of IgM-secreting cells or the number of PVP-specific IgMsecreting cells per 10 6 nucleated spleen cells.
Several different sandwich ELISA techniques were used to analyze the sera of the radiation chimeras for (i) total IgM of the lgM a and lgM b allotypes, and (ii) PVP-specific IgM of the lgM a and lgM b allotypes. The details of these sandwich ELISAs are described in Table 1 . In general, the coating reagents were incubated on high-binding EIA plates (Costar 3590) in alkaline carbonate buffer overnight at 4°C, the plates were washed four times with EWB between each intermediate step, and the intermediate reagents (diluted in EWB) were incubated on the plates for 2 h at 4°C. Purified IgM from tissue culture supernatants of the tissue culture-adapted B cell lymphoma CH34.LX (11) and from the BALB/c hybridoma BP5.1a12 (a BALB/c lgM a produced in our laboratory) were used as standards for quantification of total IgM. Tissue culture supernatant from the PVP-specific hybridoma PV1 was used to construct a standard curve of PVP-specific lgM b . Because no lgM a PVP-specific hybridomas are available, this same standard curve was also used to estimate the quantity of PVP-specific lgM a . b mice were pre-bled and immunized i.p with 1 ng PVP-360, without adjuvant Seven days later the mice were bled again and left without further manipulation for at least 100 days All mice were then bled and immunized again. After a further 7 days the mice were bled again. All sera were analyzed for PVP-specific antibodies of IgM, IgG and IgA isotypes as described in Methods Data are displayed as mean Ig concentrations with bars to indicate standard deviations
Results
The primary and secondary serological response to PVP PVP-360 acts as a standard TI-2 antigen in mice. Figure 1 shows the serum antibody response to PVP-360 immunization in normal adult mice there is an immediate IgM response which continues for at least 100 days with little diminution in titer and there is only a modest increase in IgM titer after secondary immunization. There is only a trace of lgG3 and IgA anti-PVP produced in the primary response, and no increase in these isotypes after secondary immunization No lgG1 or lgG2 is made in either primary or secondary responses, nu/nu mice respond to PVP-360 as well as mice with intact thymuses and mice bearing the X-linked immunodeficiency mutation xiddo not respond to PVP-360 at all (data not shown).
We have also used the ELISAspot technique of Sedgwick and Holt (10) to enumerate individual antibody-secreting cells. All B cells secreting IgM (regardless of specificity) can be counted on ELISA plates coated with goat anti-mouse IgM and B cells secreting IgM specific for PVP can be counted on plates coated with the smaller PVP polymer PVP-10. 
Production of PVP-specific Ig in radiation chimeras
It is widely assumed that the precursors of (at least CD5 + ) B-1 cells are absent from or are not functional in adult bone marrow (3). We therefore constructed radiation chimeras with adult bone marrow only or with adult bone marrow and adult peritoneal cells from donor mice which differ at Ig heavy chain allotype. We allowed the immune systems of these chimeric mice to reconstitute for 2 months and then immunized them with 1 u,g PVP-360, without adjuvant. Seven days later the mice were bled, and the sera assayed for total IgM and PVP-specific IgM of both allotypes. The results are shown in Table 2 .
There are two important points to be made from this Table  2 . (i) In chimeras made from BM and PerC, the PerC allotype constitutes a substantial proportion, between 28 and 46% of the total circulating IgM. (n) In chimeras made with both BM and PerC, however, at least 99% of the PVP-specific IgM is derived from B cells of the BM allotype. The transferred PerC make a substantial contribution to the total circulating IgM but essentially all of the anti-PVP IgM is made by cells derived from the adult bone marrow.
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Non-templated (N) nucleotides in the CDR3 regions of PVPspecific hybridomas
It is, at least theoretically, possible that the PVP-specific antibody of donor allotype was produced by rare, mature recirculating B-1 cells of fetal or neonatal origin that were resident in the donor bone marrow at the time of transfer. In order to determine the age at which these B cells matured from B cell precursors, we sequenced the Ig heavy chain regions from several PVP-specific hybridomas and looked for The most important point to be made from these sequences is that 10 of 16 D-J junctions contain N nucleotides, confirming their derivation from adult bone marrow-derived B cell precursors. Thirteen of 16 V-D junctions contain nucleotides which may be either V H -encoded nucleotides or N nucleotides. There is some ambiguity in assigning these nucleotides because we do not know the germhne nucleotide sequence of most of these VH genes between the 94th codon and the beginning of the heptamer signal sequence. It is very likely, however, that most of these V-D junctions contain authentic N nucleotides. Only one of the 16 PVP-specific hybridomas has heavy chains without any potential N nucleotides. There are several other points which can be made from these sequence data (i) Some VH genes are used repeatedly in several independently-derived, clonally unrelated hybridomas from the same mouse, (ii) PV2 and PV5 are clearly clonally related and indicate the occurrence of isotype switching without somatic mutation (iii) In those cases where the germline sequence of the variable regions is known (or can be inferred from multiple occurrences of independent clones with identical VH sequences) there is no evidence of any somatic mutation
Analysis of the phenotype of anti-PVP-secreting B cells by flow cytometry
We examined the phenotype of B cells making PVP-specific IgM, 5 days after a primary immunization with 1 u.g PVP-360 Splenic lymphocytes were stained with combinations of reagents directed against IgM, IgD, CD23, CD43, CD5 and B220. The cells were sorted on the basis of criteria described in the individual figures and tables, resuspended in BCM, and counted Appropriate dilutions were applied to ELISA plates which had been coated with unlabeled goat anti-mouse IgM or with PVP-10. After 2 h the plates were developed as described in Methods. We expressed the results as number of antibody-secreting cells per 1x10 6 nucleated cells. Figure 4 shows the results of an experiment in which immune spleen cells were sorted, on the basis of CD23 and Table 2 . Serological analysis of the radiation chimeras after immunization with Spleen cells from a PVP-360-immunized mouse were also sorted on the basis of expression of CD5 and the pan-B cell marker B220, and the resulting subpopulations analyzed by the ELISAspot technique. The results are summarized in Fig.  6 . Because CD5 is expressed at low levels on splenic B-1 cells and the number of B-1 cells in the spleen is low, it is difficult to completely resolve B-1 cells (on the basis of CD5 and B220 expression) from the much more numerous T cell and conventional B cell populations. To sort these rare splenic B-1 cells we analyzed PerC from the same mouse and arranged the CD5 + , B220 medium region that we applied to the PVP-immune spleen cells to enclose the majority of peritoneal B-1 cells. Sorting for a population of cells with higher average CD5 expression and clearly lower B220 expression than the bulk of the splenic B cells resulted in a striking (>20-fold) enrichment in PVP-specific IgM-secreting B cells. More than 80% of the anti-PVP-secreting B cells in the spleen are in the CD5 + , B220 medlum population, even though that population makes up only 1.4% of the lymphocytes in the spleen. The small number of CDS Another important point to be made from these data is that the same sort criteria which enrich for cells secreting PVPspecific IgM also enrich for B cells secreting IgM of any specificity. This is in complete agreement with the findings that B-1 cells are responsible for most of the circulating IgM in adult mice (14) (15) (16) (17) .
Discussion
On the basis of the hypothesis that the B-1 phenotype marks a state of differentiation induced by Tl response to antigen (1) rather than a distinct, committed lineage of cells, we predicted that B-1 cells should be inducible in adult mice, by immunization with non-self TI-2 antigen that the mouse had not encountered previously. By contrast, the lineage hypothesis would predict either that the responding cells would not be B-1 cells or that they would be derived from pre-existing cells of the B-1 phenotype. We set out to test this prediction.
The studies described above establish that: (i) at the time of maximal antibody secretion, 5 days after primary immunization of adult mice, the B cells which secrete PVPspecific IgM are, by cell-surface antigen phenotype, B-1 cells; (ii) the normal (unimmunized) adult peritoneum does not contain B cells, or the precursors of B cells, capable of responding to the TI-2 antigen PVP when transferred into irradiated, histocompatible recipients; and (iii) adult bone marrow contains cells which give rise to B cells fully capable of responding to PVP in the same irradiated recipients. Clearly, B-1 cells can be generated from precursors in the adult bone marrow following immunization with a TI-2 antigen. In addition, a set of hybridomas produced after adult immunization with PVP shows extensive N nucleotides at the V-D and D-J junctions, further indicating their derivation from adult bone marrow (18) . Our interpretation of these facts, and other studies showing severe constraints on the CDR3 structure of phosphatidylcholine (PtC)-specific antibodies which use the V H 11 and V H 12 heavy chain variable region genes (6, 19) , is that the B-1 phenotype is the consequence of encounter with TI-2 antigen and that the normal, spontaneously arising adult B-1 repertoire is the result of antigen-driven selection by (mostly) self antigens. This interpretation further implies that the capacity of spontaneously arising adult B-1 cells for self replenishment, sometimes claimed to be a 'defining characteristic of B-1 cells' (20) , is actually proliferation in response to antigen, a property common to all B and T cells. There is one important deduction that follows from our observations. Any study which interprets the lack of a specific immune response after the transfer of adult peritoneal B cells into irradiated recipients to indicate that the response could not be mediated by B-1 cells is simply invalid Similarly, any study which uses the appearance of a specific immune response in the irradiated recipients of adult bone marrow to prove that B-2 cells are responsible for such responses is also invalid. This follows from the findings that the peritoneal B cells of mice who have not been deliberately immunized do not demonstrate the full range of specificities available to B-1 cells, and that B-1 cells can be generated from precursors present in the transferred adult bone marrow. Kantor et al. (20) have also observed the generation of B-1 cells from precursors present in the adult bone marrow.
Our main goal in the studies described here was to determine the phenotype of B cells that have been selected and clonally expanded in response to an exogenous antigen. Peritoneal B cells reactive with PtC, which arise spontaneously in normal mice and which appear normally in nude mice (21) , are classic B-1 cells. They are clearly the product of antigendriven selection (6, 19) . This fact, taken together with the reported possibility to cause normal splenic B cells to express the B-1 phenotype in vitro, by cross-linking their surface IgM, in the absence of T cell interaction (7, 22, 23) , led us to predict (1) that the B-1 phenotype would be induced by immunization with exogenous thymus-independent antigens. We have shown here that B-1 cells secreting PVP-specific Ig can be generated from the adult bone marrow, as deduced from the allotype of antibody produced in radiation chimeras and from the presence of N nucleotides in the VDJ assemblies expressed by anti-PVP hybridomas This observation is much more compatible with the view that the B-1 phenotype is a marker for an antigen-driven B cell differentiation pathway, rather than for a distinct lineage of virgin, unstimulated but developmentally committed B cells.
What sets these studies apart from most previous studies on the origin of B cell subsets is that we have immunized first and then phenotyped the responding cells rather than transferring phenotyped cells into irradiated, sad or newborn mice, then immunizing and inferring the phenotype of responding cells from the allotype of the resulting antibody. Our studies have not relied on any a priori assumptions about the inducibility, permanence or reversibility of the B-1 phenotype. Although our data imply that the phenotype is inducible by antigen, we are unwilling to conclude that its continued expression is independent of antigen persistence. Furthermore, although we have studied the response to a TI-2 antigen, it is quite possible that primary responses to TD antigens may also involve B-1 cells. In the early 1970s, Carl Grumet and Hugh McDevitt showed that the primary IgM responses to synthetic polypeptides under immune response (Ir) gene control were indistinguishable in responder and nonresponder strains of mice (24, 25) . The differences between the strains were only evident during the secondary, IgG responses. Furthermore, neonatal thymectomy converted responder strains into non-responders and had no effect on the primary, IgM response. Clearly, the thymus dependence of an immune response is most apparent during the secondary, memory phase of that response. This leaves open the possibility that primary immune responses to all antigens are mediated by B cells with the B-1 phenotype. These questions are being addressed by continuing investigations.
Our interpretation is at variance with the 1984 study of Hayakawa et al. (15) who immunized NZB and CSW mice with a variety of TD antigens [sheep red blood cells (SRBC) and TNP-keyhole limpet hemocyanin] and Tl-type 1 and 2 antigens (TNP-Ficoll, TNP-LPS or TNP-BA), sorted spleen cells 4 days later on the basis of Ly-1 and IgM expression or (i/5 ratio, and assayed the sorted populations for cells which could form plaques on SRBC or on haptenated SRBC. They reported that the bulk of the B cells making antibody to any exogenous antigen were CD5" and lgM + , and that the cells making TNP-specific antibody after immunization with TNPFicoll were IgD". It may be that the apparent discrepancy between these early results and ours is due to the current availability of a greater range of antibodies to differentiation markers. 
